Healio (2/7, Herpen) reports, “As symptom severity for major depressive disorder [MDD] and treatment-resistant depression [TRD] increases, so do costs to health systems,” researchers concluded in a study including 24,534 patients with TRD and 17,628 patients with MDD. The study revealed that “patients with TRD incurred healthcare costs 1.23 times greater…than the MDD group on average within the 12 month follow-up.” In addition, “participants who reported more severe symptoms in both groups recorded higher mean costs.” The findings of the “retrospective cohort study” were published online Feb. 1 in the Journal of Clinical Psychiatry.
Related Links:
— “Health care costs rise with symptom severity in patients with MDD, TRD “Robert Herpen, Healio, February 7, 2022